Press releases

15 JUNE, 2018

Bluebee Achieves ISO 13485 Medical Device Quality Standard Certification

Rijswijk, The Netherlands June 15, 2018 – Bluebee, a global bioinformatics solutions provider, has announced today that it has been awarded the ISO 13485:2016 certification. ISO 13485 is an internationally recognized medical device quality management systems standard, which was awarded to Bluebee for its design and development of software solutions and data processing algorithms intended for use… Learn More

12 JUNE, 2018

Lexogen and Bluebee Collaborate to Streamline QuantSeq-UMI Sequencing Data Analysis Pipeline

VIENNA, AUSTRIA, AND RIJSWIJK, THE NETHERLANDS, June 12, 2018 – Lexogen, a transcriptomics and next-generation sequencing company and Bluebee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data analysis pipeline on the Bluebee genomics analysis platform. This collaboration offers QuantSeq users utilizing UMIs the opportunity to analyze samples… Learn More

16 MAY, 2018

Bluebee introduces BLUEBASE, a streamlined solution transforming data into actionable knowledge for clinical and translational genomics research

RIJSWIJK, THE NETHERLANDS, May 16, 2018 — Bluebee Corporation announced today the release of BLUEBASE, a complete data management solution designed to transform next-generation sequencing (NGS) and metadata into actionable genomic knowledge with efficiency and clinical-grade security. BLUEBASE runs on the Bluebee core data analysis platform and provides post-sequencing intelligent data aggregation, ease of querying,… Learn More

08 FEBRUARY, 2018

New England Biolabs and Bluebee Partner to Deliver an End-To-End Data Analysis Solution for NEBNext Direct Target Enrichment

RIJSWIJK, The Netherlands & Ipswich, Massachusetts, USA — February 8, 2018 – Bluebee, a company driving global genomic data-driven medicine, and New England Biolabs, Inc. (NEB®) have partnered to provide a secure and convenient data processing solution for NEB’s NEBNext Direct target enrichment technology. Through this partnership, Bluebee enables NEB’s NEBNext Direct customers the ability… Learn More

19 DECEMBER, 2017

Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market

RIJSWIJK, NETHERLANDS and IRVINE, CA, AMSTERDAM, – 19 December 2017 – Bluebee, a company driving global genomic data-driven medicine, and Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, have partnered to provide a secure, convenient, data processing solution for Agendia’s MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit, which is… Learn More

10 NOVEMBER, 2017

Lexogen and Bluebee Partner to Bring the SLAMseq Metabolic RNA Sequencing Data Analysis Pipeline to the Users

RIJSWIJK, The Netherlands and Vienna, Austria — November 10, 2017 — Bluebee, a company driving genomic data-driven medicine, and Lexogen a company enabling the analysis of the complete transcriptome, announce the successful integration of the SLAMdunk pipeline on Bluebee’s private cloud-based platform, making it available to analyze data generated by every user of the SLAMseq Metabolic… Learn More

09 OCTOBER, 2017


RIJSWIJK, The Netherlands and MENLO PARK, Calif., — October 9th, 2017 — Bluebee, a company driving genomic data-driven medicine, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, announced they have integrated the PacBio® de novo assembly pipeline onto the Bluebee® genomics analysis platform. The integration creates a simplified workflow and fully… Learn More

29 MAY, 2017

Bluebee and MediSapiens Announce Strategic Partnership

Combined Offering Provides a Comprehensive Integrated Solution For (NGS) Data Analysis And Interpretation in Healthcare And Research Finland and The Netherlands – May 29, 2017 – Today, Bluebee, a leading provider of high-performance genomics analysis and storage solutions and MediSapiens, a leading biomedical big data curation, management and interpretation company, announce a strategic partnership to… Learn More

05 MAY, 2017

Bluebee Appoints two Independent Board Members

Boston, MA & Rijswijk, The Netherlands – May 5, 2017 Bluebee Holding BV a leading provider of high performance genomics solutions, today announced the appointment of two new members to its Board of Directors. Lars Kongsbak has been appointed as an independent director, and Nicolas Roelofs will become Chairman of the Board. About Nicolas H… Learn More

20 MARCH, 2017

Bluebee Awarded With The Frost And Sullivan 2017 Enabling Technology Leadership Award

Today we announced that Bluebee has been awarded the Frost & Sullivan 2017 European Enabling Technology Leadership Award. Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that enhances current products and enables the development of new products and applications that address global challenges. We are honored… Learn More

14 DECEMBER, 2016

Bluebee Achieves HIPAA Compliance, The Highest Standards of Confidentiality and Data Protection

Just announced today, the Bluebee Genomics Platform has achieved compliance with all data security safeguards outlined in the Health Insurance Portability and Accountability Act (HIPAA). The HIPAA Security and Privacy safeguards are designed to protect Protected Health Information (PHI) for all customer data uploaded to the Bluebee Genomics Platform. This achievement was validated by an… Learn More

17 NOVEMBER, 2016

Bluebee Sucessfully Obtains Information Governance Statement of Compliance

Today we announced the Bluebee Genomics Platform and its associated processes for development and operations have successfully obtained the Information Governance Statement of Compliance (IG SoC) which includes compliance with the NHS Information Governance Toolkit. The NHS has developed its own set of rigorous information governance principles to ensure a consistent approach to the management… Learn More

06 OCTOBER, 2016

Bluebee Achieves ISO/IEC 27001:2013 Accreditation

At Bluebee we place the highest importance on data security and information governance, we are therefore pleased to announce that we have successfully achieved this major milestone. The ISO 27001:2013 certification is an independent confirmation of the strength of Bluebee’s information security management system (ISMS). Independent audit firm BSI has certified that the Bluebee Genomics Platform and the… Learn More

21 SEPTEMBER, 2016

Leading Sequencing Service Provider GATC Biotech Adopts Bluebee for Genomic Analysis

GATC Biotech, Europe’s leading provider of sequencing and bioinformatics solutions, has adopted Bluebee’s robust and scalable cloud platform to support secure, efficient and affordable data analysis. GATC will leverage the Bluebee platform to support large scale services, such as whole genome sequencing. The partnership is part of a systematic effort to offer the fastest processing… Learn More

23 MAY, 2016

Bluebee Introduces New Release with Integrated Genome Browser

The newly added features include the integration of The Broad Institute’s Integrative Genomics Viewer, the ability to add customer definable tags and metadata, as well as enhanced capabilities for flexible management of data storage. Integration of the Broad Institute’s Integrative Genomics Viewer (IGV) The Integrative Genomics Viewer ( is a high-performance visualization tool for interactive exploration of... Learn More

05 APRIL, 2016

Bluebee Teams Up With Aspera for Fast Transfer of Genomics Data for Clinical Applications

ARMONK, NY – April 5, 2016: IBM (NYSE:IBM) today announced that Bluebee, a leading provider of high-performance genomics solutions, has deployed high-speed file transfer solutions from Aspera, an IBM company, running on the IBM Cloud and integrated directly into the Bluebee genome analytics platform. Aspera transfers reduce the end-to-end turnaround time of computational data analysis, enabling... Learn More

31 MARCH, 2016

Bluebee Announces €10 Million in Series A Financing

Bluebee announced today it has raised €10 million ($11,6 million) in Series A financing from a strategic group of investors active at the crossroads of life sciences and ICT, including Capricorn ICT Arkiv, Korys and Biover II. The financing was subscribed by Bluebee’s existing shareholders, including Buysse & Partners and the management team.  The investment will support... Learn More

27 DECEMBER, 2015

CECAD Cologne and Bluebee collaborate to expand access

Bluebee and the Bioinformatics Core Facility at the CECAD Research Center of the University of Cologne are collaborating to implement QuickNGS on Bluebee’s high-performance cloud platform for genomic analysis. In a society where people are living longer, the Cologne Cluster of Excellence (CECAD) at the University of Cologne explores aging-associated disorders and their causes. More than 400... Learn More

20 SEPTEMBER, 2015

Bluebee to Chair OpenPOWER Personalized Medicine Work Group

We are proud to announce that Bluebee co-founder Dr. Zaid Al-Ars has been elected as chairman of the newly chartered OpenPOWER workgroup named the Personalized Medicine Workgroup.  The workgroup brings together technology leaders in the field and consolidates the efforts to create effective genomics computational solutions. Founding members of the workgroup are IBM, Altera Corporation, Nallatech and next generation sequencing data... Learn More

19 MAY, 2015

Bluebee raises €1.75 million investment

Bluebee announced toady it has raised 1.75 million EUR (1.90 million USD) from Belgian investment firm Buysse & Partners and existing shareholder Delft University of Technology to bring its cloud-based, accelerated genomics solution to clinicians and labs. Bluebee’s technology, based on hybrid-core computing (FPGA) allows clinicians to shorten the time-to-diagnosis substantially. “Our technology solves the... Learn More

22 SEPTEMBER, 2014

Bluebee Joins the OpenPOWER Foundation

Bluebee has joined the OpenPOWER Foundation, an open development community that leverages the IBM POWER architecture. Bluebee is glad to join IBM, Google, Altera, Xilinx and a growing number of technology organizations working collaboratively to build advanced server, storage, and networking acceleration technology as well as industry leading open source software aimed at delivering more... Learn More

07 SEPTEMBER, 2014

Convey Computer and Bluebee Partner to Strengthen Offering

Richardson, Texas and Delft, The Netherlands–September 8, 2014–Bluebee, a next generation sequencing data analysis provider and Convey Computer Corporation, the leader in hybrid-core computing for accelerating data analytics, today announced a distribution agreement that strengthens both companies’ bioinformatics offerings. The partnership promotes increased innovation for bioinformatics technologies and advanced solutions for next-generation sequencing research. The... Learn More

Sign up for our newsletter

Our latest news, publications and developments delivered to your inbox